The idea of a tan from a vial gets attention. What matters for anyone comparing legal, prescription-based providers is narrower and more useful: which of these compounds a licensed clinician can actually prescribe, which a pharmacy can legitimately dispense, and what separates a real channel from a gray market one.
The melanocortin family gets grouped together because the compounds act on related receptors, but their legal footing is very different. That difference should drive how you read any provider's menu.
The three names you will see
Melanotan I and Melanotan II are the pigmentation-associated peptides most often referenced in tanning discussions. Neither is an FDA-approved drug in the United States. That single fact tells you most of what you need to know about how they circulate.
Bremelanotide is the outlier. It is FDA approved under the brand name Vyleesi for a specific indication in women and is the same molecule discussed in peptide circles as PT-141. Because it cleared the approval process, it exists inside the regulated prescription system in a way the Melanotan compounds do not.
Why the legal status changes your options
When a peptide has no FDA approval and no accepted status as a compounding ingredient, licensed pharmacies generally will not touch it. What fills that vacuum is a research-use-only supply chain: vials labeled not for human use, sold by vendors who make no medical claims and take no responsibility. That is the environment most Melanotan II sits in, and it is not a channel this directory treats as a place to buy.
An approved product is different. A clinician evaluates you, writes a prescription for an on-label or clearly defined use, and a licensed pharmacy dispenses a product made under manufacturing standards. You get a labeled drug, a chain of accountability, and a professional who can answer for the decision.
What drives cost in the legitimate channel
For an approved product like bremelanotide, price reflects the manufacturer, the pharmacy, and whether you are getting a branded product or a compounded version prepared under the rules that govern 503A and 503B facilities. Insurance rarely covers peptides used outside their approved indication, so most people pay cash, and the telehealth consult fee is often bundled into what a provider quotes.
A wide gap between two quotes usually comes down to product source and what the fee includes, not a bargain. If one number is far below the rest, ask what you are actually receiving and who compounded or manufactured it.
How to vet a provider
The questions are the same regardless of the compound, and they get sharper when the compound is investigational or not approved at all.
- Is there a licensed clinician who evaluates you before anything is prescribed, and can you reach them with questions later?
- Does the medication come from a state-licensed 503A pharmacy or an FDA-registered 503B outsourcing facility, and will they name it?
- Will they tell you the exact compound, its regulatory status, and its source in writing?
- Do they avoid marketing an unapproved peptide for a cosmetic result?
A provider who answers those plainly is easy to compare on cost and service. One who dodges them is telling you something about the product before you ever open the box.
The bottom line
If you are shopping the melanocortin peptides through legal channels, bremelanotide is the one with a defined path through licensed pharmacies via a prescription. The Melanotan compounds do not share that status in the United States, and a legitimate provider will not pretend otherwise. Bring any specific question about your own situation to a licensed clinician, who can weigh what is approved, what is investigational, and what makes sense for you.